NCT04560738View on ClinicalTrials.gov

A Study to Evaluate the Metabolism and Excretion of [14C]-CC-92480 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

May 13, 2021

Study Completion Date

May 13, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

[14C]-CC-92480

Oral

Trial Locations (1)

53704

Covance Clinical Research Unit Inc, Madison

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY